H

HTL Biotechnology Tech Stack

Pharmaceutical-grade biopolymer development and manufacturing in France and the US

Biotechnology Research JAVENE, Bretagne 201–500 employees Founded 1992 Self-Owned

HTL Biotechnology manufactures pharmaceutical-grade biopolymers—primarily hyaluronic acid and polynucleotides—for ophthalmology, dermatology, medical aesthetics, and rheumatology applications. The company's tech stack (Python, GCP, Power BI, Salesforce) and active projects reveal a manufacturing operation scaling fermentation and quality workflows: laboratory optimization, pilot fermentation, LIMS integration, and CAPA management are all in motion. Pain points around process optimization and quality compliance align with a production-focused organization moving from manual lab practices toward data-driven manufacturing.

Tech Stack 15 technologies

Core StackJavaScript Python React Vue Active Directory Power BI Tableau Salesforce HTML CSS SQL Microsoft 365 Genially Excel GCP

What HTL Biotechnology Is Building

◆Challenges

Refonte logiciel accueil visiteurs
Gestion d'accès à la zrr
Optimizing fermentation process
Ensuring product quality compliance
Managing deviations and capa
Optimizing post-treatment processes
Lack of market insight
Inconsistent customer data
Reducing workplace accidents
Implementing hris

▲Active Projects

Développement application web accueil visiteurs
Method development and validation
Implementation of new equipment
Continuous improvement of lab practices
Laboratory fermentation optimization
Pilot scale fermentation experimentation
Post-treatment labeling and lims integration
Quality deviation capa management
Enrichir qrcode
Study formulation parameters on polymer network

Hiring Activity

Steady25 roles · 9 in 30d

Department

Research

5

Manufacturing

4

Engineering

3

Ops

3

HR

2

Legal

2

Support

2

Data

1

Seniority

Intern

9

Mid

6

Senior

5

Junior

4

Company intelligence

Find more companies like HTL Biotechnology by tech stack, pain points and active projects

Get started free

About HTL Biotechnology

HTL Biotechnology is a French biotech founded in 1992, headquartered in Javené, Brittany, with ~300 employees across France, the United States, and Asia. The company develops and manufactures pharmaceutical-grade biopolymers used in regenerative medicine and drug delivery, serving healthcare companies across four therapeutic areas. Recent expansion includes a US recombinant protein platform (recombinant human collagen type III) acquired through a New Jersey subsidiary, and a new neuromodulator production facility in Massachusetts. The core business combines research, development, production, and quality control, with active hiring across research, manufacturing, engineering, and operations.

HeadquartersJAVENE, Bretagne

Company Size201–500 employees

Founded1992

Hiring MarketsFrance, United States

Frequently Asked Questions

What is HTL Biotechnology's main product?

HTL manufactures pharmaceutical-grade biopolymers, primarily hyaluronic acid and polynucleotides, for use in ophthalmology, dermatology, medical aesthetics, rheumatology, and regenerative medicine applications.